IP Basics

Where are the Women in IPR?

James Watt invented steam engines, Alexander Graham Bell invented the telephone, the Wright Brothers invented airplane; whereas Thomas Edison is attributed with the invention of electric light bulb to the phonograph to the motion picture camera (he filed more than 1000 patents for his inventions). We all know these scientists who have made our [...]

By |2017-09-08T12:02:28+05:30March 21st, 2017|IP Basics|0 Comments

Negotiating Access to University IP

The content in this article builds upon a webinar delivered by Owen for Patsnap on the 27th of January 2017).There is a vast amount of ways in which you can structure intellectual property collaboration between a university and business. This article looks to provide guidance and points for consideration by both sides. University patents [...]

By |2017-09-08T12:05:02+05:30March 15th, 2017|IP Basics|0 Comments

Plain Apathy or Sheer Incompetence?

The discussion came up in the context of National AIDS Control Programme (NACO) facing reverses due to the dwindling of stocks of anti-retroviral medication. Two years hence, the government and its bureaucracy, in a shocking display of indifference towards the children living with HIV, have turned a blind eye towards the running out of [...]

By |2017-09-08T12:05:38+05:30March 15th, 2017|IP Basics|0 Comments

EUIPO ranked world’s most innovative IP office in exclusive research !

The latest issue of World Trademark Review magazine is now available online to subscribers. In this issue, we undertook an ambitious research project to identify the IP offices around the world that are committed to exploring value-add non-core offerings for its users. The EU Intellectual Property Office (EUIPO) topped the final ranking, reflecting its [...]

By |2017-09-08T12:10:34+05:30March 10th, 2017|IP Basics, Patent|0 Comments

Bayer’s Nexavar: Under Bolar Exemption

In a significant development today, Justice Endlaw of the Delhi High Court held that ‘export’ of a patented invention for experimental purposes is also covered under Section 107A of the Patents Act, 1970 (India’s Bolar exemption) and thus does not amount to patent infringement. It accordingly allowed Natco to export Bayer’s patented drug ‘Sorafenib [...]

By |2017-09-08T12:26:45+05:30March 9th, 2017|USA, IP Basics|0 Comments
Go to Top